| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,299 |
5,607 |
$156K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,048 |
2,631 |
$104K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,651 |
1,131 |
$66K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,203 |
854 |
$54K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
481 |
373 |
$33K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
723 |
470 |
$26K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,182 |
2,199 |
$5K |
| 92552 |
|
2,759 |
1,766 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,945 |
703 |
$1K |
| 90670 |
|
382 |
284 |
$900.25 |
| 90686 |
|
148 |
97 |
$521.88 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,407 |
965 |
$517.17 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
921 |
557 |
$323.41 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
311 |
184 |
$289.08 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
195 |
127 |
$273.32 |
| 90461 |
|
939 |
633 |
$235.05 |
| 92551 |
|
51 |
51 |
$78.76 |
| 90651 |
|
47 |
28 |
$70.00 |
| 90620 |
|
60 |
33 |
$60.00 |
| 99442 |
|
23 |
22 |
$17.65 |
| 99173 |
|
2,201 |
1,383 |
$3.43 |
| 81002 |
|
64 |
42 |
$2.10 |
| 90660 |
|
32 |
24 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
78 |
39 |
$0.00 |
| A7015 |
Aerosol mask, used with dme nebulizer |
51 |
26 |
$0.00 |
| 90680 |
|
13 |
13 |
$0.00 |
| 90716 |
|
31 |
15 |
$0.00 |
| G8539 |
Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment |
59 |
47 |
$0.00 |
| 90707 |
|
44 |
27 |
$0.00 |
| 90734 |
|
77 |
52 |
$0.00 |
| 90648 |
|
157 |
114 |
$0.00 |
| 90700 |
|
35 |
33 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
13 |
$0.00 |
| 90713 |
|
20 |
20 |
$0.00 |
| 90715 |
|
22 |
12 |
$0.00 |